eCential Robotics Appoints Experienced Leadership Team to Drive U.S. Market Expansion

eCential Robotics, a growth company transforming bone surgery by designing and manufacturing an open robotic and navigation system with unique capabilities, is pleased to announce the addition of Lisa Jacobs and Matthieu Ville to its leadership team. These strategic hires come as part ofeCential Robotics’ commitment to accelerating its growth and innovation in the U.S. […]

Anytime AI CEO Presents at TEDx, Bringing Legal AI to the Main Stage

In a groundbreaking first for TEDx, Legal Artificial Intelligence (AI) took center stage as Dr. Lingfei (Teddy) Wu, CEO and co-founder ofAnytime AI, delivered a captivating talk at TEDxCSTU on July 28th, 2024. Dr. Wu’s talk, titled ‘AI in Law: A Mandate, Not an Option,’ marked a pivotal moment in the legal industry, showcasing how

QurAlis Announces Expansion of its Selective Kv7.2/7.3 Ion Channel Opener, QRL-101, Into Epilepsy

QRL-101 is the only Kv7.2/7.3 ion channel opener being actively studied for the treatment of hyperexcitability-induced disease progression in ALS Kv7.2/7.3 is a clinically validated target to regulate the hyperexcitable state in epilepsy Company initiates exploratory Phase 1 proof-of-mechanism study in healthy volunteers to characterize the potential anti-seizure effects of QRL-101 QurAlis Corporation (“QurAlis”), a

Banzai Announces Reverse Split to Regain NASDAQ Compliance

SEATTLE, Sept. 19, 2024 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that effective at 12:01 a.m., EDT, on September 19, 2024, the Company will effect a one-for-fifty (1 for 50) reverse stock split of its outstanding

POET and Mitsubishi Electric Collaborate to Develop 3.2T Optical Engines for AI Networks

TORONTO, Sept. 19, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer(TM), Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and AI markets, today announced it has entered into a collaboration with Mitsubishi Electric Corporation

EQ Bank launches Business Account beta, a new banking solution to better serve small business owners

— EQ Bank Business Account transforms Canadian business banking with high interest, no fees, unlimited transactions* and access to Business GICs, supported by an entirely digital onboarding experience — Beta phase of launch provides account access to existingEQ Bank customers EQ Bank, the digital arm of Canada’sChallenger Bank™ with a mission to drive change in

MIT Sloan researchers develop first-of-their-kind algorithms to balance fairness of item display and user preferences in online marketplaces

Cambridge, MA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Online marketplace platforms often prioritize top-selling or well-known products in their item displays. Such favoritism, however, can limit content diversity and raise concerns about fair competition. From the user’s perspective, platforms aimed at maximizing revenue may not align with their preferences. This focus can lead to an

Did Acadia Healthcare Company, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate – ACHC

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Acadia Healthcare Company, Inc. ("Acadia Healthcare Company, Inc.") (NASDAQ:ACHC) concerning possible violations of federal securities laws. The New York Times published a report on September 1, 2024, entitled "How a Leading Chain of

ATTENTION EW SHAREHOLDERS: Investors who lost money on Edwards Lifesciences Corporation are urged to contact Levi & Korsinsky about an ongoing investigation

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for

Scroll to Top